Clinical Trial Update: Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients [Phase 4]

View source ↗

Summary

Phase 4 trial of botulinum toxin type A for neuropathic pain in spinal cord injury patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Catholic University of Korea Saint Paul's Hospital | Conditions: Spinal Cord Injury, Neuropathic Pain | Phase 4 | Status: COMPLETED